These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 646547)

  • 21. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
    Mehta J; Iacona M; Pepine CJ; Conti CR
    Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
    Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure.
    Awan NA; Miller RR; Mason DT
    Circulation; 1978 Jan; 57(1):152-9. PubMed ID: 618383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
    Rouleau JL; Chatterjee K; Benge W; Parmley WW; Hiramatsu B
    Circulation; 1982 Apr; 65(4):671-8. PubMed ID: 7037220
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prazosin in the treatment of chronic cardiac insufficiency].
    Champoud O; Cribier A; Letac B
    Ann Med Interne (Paris); 1985; 136(3):261-5. PubMed ID: 2862824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemodynamic effects of prazosin in chronic congestive heart failure].
    Bassand JP; Becque O; Berthout P; Vial Y; Magnin D; Bernard Y; Maurat JP
    Arch Mal Coeur Vaiss; 1980 Jun; 73(6):747-56. PubMed ID: 6779769
    [No Abstract]   [Full Text] [Related]  

  • 27. [Echocardiographic changes in severe congestive heart failure treated with prazosin].
    Scandiffo T; Veglia L; Guerricchio G
    Boll Soc Ital Cardiol; 1979; 24(6):695-7. PubMed ID: 551803
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the long-term effects of prazosin and hydralazine in chronic congestive heart failure.
    Rutishauser W
    Eur Heart J; 1983 Jan; 4 Suppl A():149-52. PubMed ID: 6840121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
    Colucci WS
    Ann Intern Med; 1982 Jul; 97(1):67-77. PubMed ID: 6124197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
    Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W
    Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alternatives to digitalis therapy].
    Larbig D; Nasse H
    Dtsch Med Wochenschr; 1983 Nov; 108(45):1725-9. PubMed ID: 6354664
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute hemodynamic and long-term clinical effects of prazosin in the treatment of chronic congestive heart failure.
    von der Lippe G; Ohm OJ; Lund-Johansen P
    Acta Med Scand; 1981; 210(3):213-6. PubMed ID: 7293839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
    Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Provocation of myocardial ischemic events during initiation of vasodilator therapy for severe chronic heart failure. Clinical and hemodynamic evaluation of 52 consecutive patients with ischemic cardiomyopathy.
    Packer M; Meller J; Medina N; Yushak M; Gorlin R
    Am J Cardiol; 1981 Nov; 48(5):939-46. PubMed ID: 7304442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
    Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
    Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
    [No Abstract]   [Full Text] [Related]  

  • 39. Current concepts in the treatment of congestive heart failure.
    Levine TB
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):147S-150S. PubMed ID: 6099731
    [No Abstract]   [Full Text] [Related]  

  • 40. Afterload reduction therapy in acute and chronic ischemic heart disease.
    Mason DT
    Arch Inst Cardiol Mex; 1977; 47(6):770-7. PubMed ID: 416760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.